We are proud to present the 6th episode of our successful All Things Urticaria Podcst Series
In this episode, Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Do you have suggestions for future episodes? Please reach out to us via email or fill out this form here and offer your suggestions for future topics and expert selection!
Read more news regarding urticaria
Podcast
November 8, 2023Professor Riccardo Asero joins Professor Marcus Maurer to offer advice on the use of non-steroidal anti-inflammatory drugs (NSAID) in people with chronic spontaneous urticaria (CSU). The experts discuss risk assessment [...]
New centers,News
October 26, 2023A very warm welcome to our 4th UCARE Center in the United States: Miami Itch Ctr Dr. Phillip Frost under Head Gil Yosipovitch. Welcome to the UCARE family, we are [...]
News
October 26, 2023Professor Marcus Maurer is joined by Professor Eduardo Souza Lima to explore the relationship between stress and urticaria, and the implications of mast cells and neuropeptides in chronic spontaneous urticaria. [...]
